+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07856797

Study to Confirm Long-Term Safety and Effectiveness of RADIESSE Injectable Implant for Moderate to Severe Nasolabial Folds

Led by Merz North America, Inc. · Updated on 2026-10-29

163

Participants Needed

8

Research Sites

78 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the long-term safety, effectiveness, and breakdown of RADIESSE Injectable Implant for treating moderate to severe nasolabial folds NLFs in Chinese adults. The study focuses on confirming how well this implant improves wrinkle severity and overall aesthetic appearance over time. Participants will receive a single injection of RADIESSE into both nasolabial folds on the first day. At the investigators discretion, an optional touch-up injection may be given one month later. The treatment follows current product guidelines and instructions. After the last treatment, participants will be monitored for up to 24 months. During the study, participants will be assessed using scales that measure wrinkle severity and aesthetic improvement, both by the investigator and by the participant. The primary outcome is the percentage of participants achieving at least a one-point improvement in wrinkle severity six months after the last treatment. Safety and effectiveness will be closely tracked throughout the follow-up period.

CONDITIONS

Brief Title

A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds

Research Team

P

Public Disclosure Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here